{"acute graft versus host disease": 14.17, "acute myeloid leukaemia": 18.92, "alanine aminotransferase increased": 2.18, "anaemia": 13.4, "basal cell carcinoma": 19.78, "bk virus infection": 29.91, "blood lactate dehydrogenase increased": 6.47, "bone pain": 2.14, "c-reactive protein increased": 2.53, "chronic graft versus host disease": 33.4, "concomitant disease aggravated": 10.05, "cytomegalovirus infection": 18.89, "cytomegalovirus infection reactivation": 38.83, "cytopenia": 29.32, "disease recurrence": 4.32, "epstein-barr virus infection reactivation": 43.62, "graft versus host disease": 9.06, "haematocrit decreased": 11.09, "haemoglobin abnormal": 24.3, "haemoglobin decreased": 14.23, "infection": 2.58, "leukocytosis": 21.75, "leukopenia": 2.83, "lymphopenia": 4.65, "maligt neoplasm progression": 3.23, "multiple organ dysfunction syndrome": 2.41, "myelofibrosis": 178.01, "neutrophil count increased": 20.81, "night sweats": 3.18, "pancytopenia": 3.67, "platelet count abnormal": 45.03, "platelet count decreased": 11.56, "platelet count increased": 30.72, "pneumonia": 2.19, "primary myelofibrosis": 656.26, "product use in unapproved indication": 16.4, "product use issue": 2.75, "pulmonary tuberculosis": 22.61, "red blood cell count decreased": 5.54, "respiratory failure": 2.65, "second primary maligcy": 168.74, "sepsis": 3.49, "septic shock": 2.53, "skin lesion": 2.75, "spleen disorder": 59.09, "splenomegaly": 108.66, "squamous cell carcinoma": 61.6, "squamous cell carcinoma of skin": 62.11, "therapeutic response decreased": 8.88, "therapy non-responder": 10.6, "therapy partial responder": 28.35, "thrombocytopenia": 12.64, "thrombocytosis": 31.3, "tuberculosis": 13.86, "weight increased": 2.64, "white blood cell count decreased": 2.2, "white blood cell count increased": 14.48, "withdrawal syndrome": 2.38}